– UK, London – The Biotech Growth Trust PLC (LON: BIOG) today announced the appointment of Roger Yates to its Board as an independent non-executive Director and Chairman-designate, effective from 1 December 2021, to succeed Chairman, Andrew Joy who will retire at the next AGM in July 2022.
“My fellow Directors and I are delighted to welcome Roger Yates to the Board. We are very pleased to have appointed an experienced Director with such extensive expertise both in investment management and in the investment companies sector.” said Board Chairman, Andrew Joy.
About Roger Yates
Roger Yates is a non-executive director, senior independent director and remuneration committee chair at St James’s Place Plc and Jupiter Fund Management plc. He is also a non-executive director and senior independent director at Mitie Group plc.
Mr Yates started his career in investment management at GT Management in 1981 and subsequently held positions at Morgan Grenfell and Invesco as Chief Investment Officer. He was appointed Chief Executive Officer of Henderson Group plc in 1999 and led the company for a decade. More recently, Roger was the Senior Independent Director and Remuneration Committee Chairman at IG Group Holdings plc, Chairman of Electra Private Equity PLC and Chairman of Pioneer Global Asset Management S.p.A. He was also a Non-Executive Director of JPMorgan Elect plc from 2008 until 2018.
For more information: https://www.biotechgt.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
